TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
- PMID: 18256672
- DOI: 10.1038/nature06537
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
Abstract
Successful vaccines contain not only protective antigen(s) but also an adjuvant component that triggers innate immune activation and is necessary for their optimal immunogenicity. In the case of DNA vaccines, this consists of plasmid DNA; however, the adjuvant element(s) as well as its intra- and inter-cellular innate immune signalling pathway(s) leading to the encoded antigen-specific T- and B-cell responses remain unclear. Here we demonstrate in vivo that TANK-binding kinase 1 (TBK1), a non-canonical IkappaB kinase, mediates the adjuvant effect of DNA vaccines and is essential for its immunogenicity in mice. Plasmid-DNA-activated, TBK1-dependent signalling and the resultant type-I interferon receptor-mediated signalling was required for induction of antigen-specific B and T cells, which occurred even in the absence of innate immune signalling through a well known CpG DNA sensor-Toll-like receptor 9 (TLR9) or Z-DNA binding protein 1 (ZBP1, also known as DAI, which was recently reported as a potential B-form DNA sensor). Moreover, bone-marrow-transfer experiments revealed that TBK1-mediated signalling in haematopoietic cells was critical for the induction of antigen-specific B and CD4(+) T cells, whereas in non-haematopoietic cells TBK1 was required for CD8(+) T-cell induction. These data suggest that TBK1 is a key signalling molecule for DNA-vaccine-induced immunogenicity, by differentially controlling DNA-activated innate immune signalling through haematopoietic and non-haematopoietic cells.
Similar articles
-
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.Nature. 2007 Jul 26;448(7152):501-5. doi: 10.1038/nature06013. Epub 2007 Jul 8. Nature. 2007. PMID: 17618271
-
Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.Vaccine. 2007 Aug 21;25(34):6341-7. doi: 10.1016/j.vaccine.2007.06.016. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17628235
-
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.Vaccine. 2005 Jan 26;23(10):1258-64. doi: 10.1016/j.vaccine.2004.09.001. Vaccine. 2005. PMID: 15652668
-
Intracellular detection and immune signaling pathways of DNA vaccines.Expert Rev Vaccines. 2009 Sep;8(9):1161-70. doi: 10.1586/erv.09.79. Expert Rev Vaccines. 2009. PMID: 19722890 Review.
-
Intracellular DNA sensors in immunity.Curr Opin Immunol. 2008 Aug;20(4):383-8. doi: 10.1016/j.coi.2008.05.009. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573338 Review.
Cited by
-
New components of the necroptotic pathway.Protein Cell. 2012 Nov;3(11):811-7. doi: 10.1007/s13238-012-2083-9. Epub 2012 Oct 17. Protein Cell. 2012. PMID: 23073834 Free PMC article. Review.
-
Understanding nucleic acid sensing and its therapeutic applications.Exp Mol Med. 2023 Nov;55(11):2320-2331. doi: 10.1038/s12276-023-01118-6. Epub 2023 Nov 9. Exp Mol Med. 2023. PMID: 37945923 Free PMC article. Review.
-
NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.Hum Vaccin Immunother. 2013 Oct;9(10):2189-95. doi: 10.4161/hv.25699. Epub 2013 Jul 24. Hum Vaccin Immunother. 2013. PMID: 23884215 Free PMC article.
-
Taming lupus-a new understanding of pathogenesis is leading to clinical advances.Nat Med. 2012 Jun 6;18(6):871-82. doi: 10.1038/nm.2752. Nat Med. 2012. PMID: 22674006 Free PMC article. Review.
-
Immunomodulatory functions of type I interferons.Nat Rev Immunol. 2012 Jan 6;12(2):125-35. doi: 10.1038/nri3133. Nat Rev Immunol. 2012. PMID: 22222875 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous